Complement Inhibitor Therapy for Myasthenia Gravis

Overview of attention for article published in Frontiers in immunology, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 14 X users

patent: 1 patent
facebook: 1 Facebook page

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 67 Mendeley

Summary News Policy documents X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF MYASTHENIA GRAVIS

Application WO-2023287991-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.